Brevetti EPO No.3322731 2021.01.13
Brevetti EPO
(10) Registration Number and Date
2021000131 2021.03.11
Status
Registered
(180) Expiration Date
(20) Filing Number and Date
SM /T/2021/000131 2016.07.14
(40) Publication Number and Date
SM /T/2021/000131 2021.03.11
(30) Priority Details
US 201562192396 P
2015.07.14
(51) IPC Classes
(72) Inventor
(IT) ANDERSON, Jeffrey : Rt. 206&Province Line Road, Princeton, New Jersey 08543, US
(IT) MANEKAS, Demetrios : 14 Yosemite Road, Howell, New Jersey 07731, US
(74) Representative Name
(IT) TRUPIANO, Federica : Via 28 Luglio, 187, 47893 Borgo Maggiore RSM, SM
(54) Title
(IT) METODO DI TRATTAMENTO DI UN CANCRO USANDO UN INIBITORE DI CHECKPOINT IMMUNITARI; ANTICORPO CHE SI LEGA AL RECETTORE DELLA MORTE PROGRAMMATA-1 (PD-1) O AL LIGANDO DELLA MORTE PROGRAMMATA 1 (PD-L1)
(EN) METHOD OF TREATING CANCER USING IMMUNE CHECKPOINT INHIBITOR; ANTIBODY THAT BINDS TO PROGRAMMED DEATH-1 RECEPTOR (PD-1) OR PROGRAMMED DEATH LIGAND 1 (PD-L1)
(57) Abstract
(58) Citations
Document Type Date Action
Traduzione 2021.07.12
Event NameDateStatus
Filing2016.07.14Filed
Brevetto EPO concesso2021.03.11Published
Ricevuta pagamento annualita 62021.06.30Payed
Ricevuta pagamento annualita 72022.06.30Payed
Ricevuta pagamento annualita 82023.06.28Payed
Ricevuta pagamento annualita 92024.06.24Payed